|
Volumn 29, Issue 2, 2002, Pages 61-67
|
Interleukin-2 activation of haematopoietic stem cells
a b b b b b b b b b b b b b b
a
Hematooncology
*
(Czech Republic)
|
Author keywords
Autologous haematopoietic stem cell transplantation; Immunotherapy; Interleukin 2
|
Indexed keywords
RECOMBINANT INTERLEUKIN 2;
ADOPTIVE IMMUNOTHERAPY;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BONE MARROW CELL;
CANCER CELL;
CELL ACTIVATION;
CELL CULTURE;
CHRONIC MYELOID LEUKEMIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLONY FORMING UNIT GM;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CULTURE MEDIUM;
DRUG SAFETY;
FLOW CYTOMETRY;
HEMATOPOIETIC STEM CELL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
HUMAN CELL;
MICROBIAL CONTAMINATION;
MULTIPLE MYELOMA;
NATURAL KILLER CELL;
PERIPHERAL BLOOD STEM CELL;
POLYMERASE CHAIN REACTION;
RELIABILITY;
STEM CELL;
T LYMPHOCYTE;
TUMOR IMMUNITY;
BONE MARROW;
BONE MARROW CELLS;
CELLS, CULTURED;
FLOW CYTOMETRY;
HEMATOPOIETIC STEM CELLS;
INTERLEUKIN-2;
LEUKEMIA, MYELOID, CHRONIC;
LYMPHOCYTE COUNT;
MULTIPLE MYELOMA;
POLYMERASE CHAIN REACTION;
REGRESSION ANALYSIS;
|
EID: 0036038998
PISSN: 03038173
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1563-2571.2002.02005.x Document Type: Article |
Times cited : (2)
|
References (29)
|